Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore ‌a shift ​to approaching the brain-wasting disease as a system of ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

Frits Stulp, Implement Consulting, says AI and global collaboration are key to addressing patent cliffs and accelerating ...

Beyond entrepreneurship, the REE-EEI project focuses on equipping participants with market-ready vocational skills.

The students were able to uncover a molecular structural discrepancy more than a decade ago, clearing a path for development ...

EBRD and European Union support DLOC Biosystems and the Lebanese American University Industrial Hub in collaboration to scale ...

Buba Marwa, Chairman/Chief Executive Officer of the National Drug Law Enforcement Agency (NDLEA), has said the newly launched ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Why it matters: Fourteen companies in total have now reached what the administration calls most-favored-nation pricing deals. They agreed to charge the U.S. government no more for new drugs than the ...

For Jacob Van Naarden, Executive Vice President and President of Lilly Oncology, the mission is clear: bring better cancer ...

Ionetix, a mid-Michigan cancer treatment company, receives workforce development funding to train employees in advanced drug development technology.